This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018
Title: Wha Il Choi: Innovator in Pharmaceutical Chemistry
Introduction
Wha Il Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target protein kinases.
Latest Patents
Wha Il Choi holds a patent for "Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase." This invention relates to a novel bicyclic heteroaryl derivative, along with its pharmaceutically acceptable salts, hydrates, and solvates. The compound demonstrates improved inhibitory activity for protein kinases and is part of a pharmaceutical composition aimed at preventing or treating abnormal cell growth disorders.
Career Highlights
Throughout his career, Wha Il Choi has worked with prominent companies in the pharmaceutical industry, including Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His work has focused on innovative solutions to complex medical challenges.
Collaborations
Wha Il Choi has collaborated with several professionals in his field, including Seung Hyun Jung and Young Hee Jung. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Wha Il Choi is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative approach to developing protein kinase inhibitors showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile